--- title: CDMOs offering Sterile Fill-Finish & Aseptic Manufacturing with Cell Therapy path: /explore/sterile-fill-finish/cell-therapy companies_count: 19 --- # CDMOs offering Sterile Fill-Finish & Aseptic Manufacturing with Cell Therapy 19 published CDMOs match Sterile Fill-Finish & Aseptic Manufacturing and Cell Therapy. Locations in this set include United States, China, United Kingdom, Denmark, Japan, and India. Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Cell Therapy Manufacturing, CMC Regulatory Submission Support, and Technology Transfer. ## Matching companies - [AGC Biologics](/companies/agcbio) - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. - [Akron Bio](/companies/akronbiotech) - Akron Bio manufactures cGMP-compliant recombinant proteins, media, buffers, and transfection reagents for cell and gene therapy companies. Services span process development, fill-finish, and custom ancillary product manufacturing. - [Aldevron](/companies/aldevron) - Aldevron is a CDMO specializing in mRNA manufacturing with LNP encapsulation and fill/finish, viral vector production, plasmid DNA, and gene therapy solutions from discovery through commercialization. - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [CDMO Network](/companies/cdmonetwork) - CDMO Network is a biomanufacturing partner-routing platform that connects biotech sponsors with specialized CDMO partners across modalities, development stages, and geographies to reduce integration friction and accelerate program execution. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Cellipont Bioservices](/companies/cellipont-bioservices) - Cellipont Bioservices is a cell therapy CDMO offering end-to-end development, analytical, and cGMP manufacturing services for autologous, allogeneic, CAR-T, and iPSC-derived therapies from preclinical through commercial stages. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [Dr. Reddy's Laboratories](/companies/drreddys) - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing. - [FUJIFILM Biotechnologies](/companies/fujifilm-biotechnologies) - CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities. - [Made Scientific](/companies/madescientific) - Cell therapy CDMO offering end-to-end development, GMP manufacturing, and regulatory support from preclinical through commercial scale, with specialized expertise in T cells, NK cells, MSCs, iPSCs, and other cell modalities. - [National Resilience](/companies/resilience) - End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities. - [Oxford Biomedica](/companies/oxb) - Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Pluri](/companies/pluri-biotech) - Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production. - [Porton Advanced](/companies/porton-advanced) - End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. - [Symbiosis Pharmaceutical Services](/companies/symbiosis-pharma) - UK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S. - [eXmoor Pharma](/companies/exmoorpharma) - Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.